AR and prostate carcinoma: After evaluating SNPs in the binding sites of estrogen and androgen receptors, it was found that the 5 SNPs localized on ARRDC3, TACC2, SKAP1, FLT1, and BNC2 are specifically associated with prostate cancer mortality [149].